{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T03:51:05Z","timestamp":1785210665457,"version":"3.55.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T00:00:00Z","timestamp":1538524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,18]]},"DOI":"10.1093\/cid\/ciy842","type":"journal-article","created":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T00:15:05Z","timestamp":1538180105000},"page":"84-90","source":"Crossref","is-referenced-by-count":25,"title":["Invasive Pneumococcal Disease in UK Children <1 Year of Age in the Post\u201313-Valent Pneumococcal Conjugate Vaccine Era: What Are the Risks Now?"],"prefix":"10.1093","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3196-2355","authenticated-orcid":false,"given":"Alison","family":"Kent","sequence":"first","affiliation":[{"name":"Paediatric Infectious Diseases Research Group and Vaccine Institute, Institute of Infection and Immunity, St Georges, University of London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Makwana","sequence":"additional","affiliation":[{"name":"Department of Immunisation, Hepatitis and Blood Safety"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen L","family":"Sheppard","sequence":"additional","affiliation":[{"name":"Respiratory and Vaccine Preventable Bacteria Reference Unit, National Infection Service, Public Health England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Collins","sequence":"additional","affiliation":[{"name":"Department of Immunisation, Hepatitis and Blood Safety"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman K","family":"Fry","sequence":"additional","affiliation":[{"name":"Respiratory and Vaccine Preventable Bacteria Reference Unit, National Infection Service, Public Health England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul T","family":"Heath","sequence":"additional","affiliation":[{"name":"Paediatric Infectious Diseases Research Group and Vaccine Institute, Institute of Infection and Immunity, St Georges, University of London"},{"name":"St George\u2019s University Hospitals National Health Service Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Ramsay","sequence":"additional","affiliation":[{"name":"Department of Immunisation, Hepatitis and Blood Safety"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamez N","family":"Ladhani","sequence":"additional","affiliation":[{"name":"Paediatric Infectious Diseases Research Group and Vaccine Institute, Institute of Infection and Immunity, St Georges, University of London"},{"name":"Department of Immunisation, Hepatitis and Blood Safety"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,10,3]]},"reference":[{"key":"2019061801001764600_CIT0001","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","article-title":"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"GBD 2015 Mortality and Causes of Death Collaborators;","year":"2016","journal-title":"Lancet"},{"key":"2019061801001764600_CIT0002","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12879-016-1553-8","article-title":"Epidemiology and outcome of sepsis in adult patients with Streptococcus pneumoniae infection in a Norwegian county 1993\u20132011: an observational study","volume":"16","author":"Askim","year":"2016","journal-title":"BMC Infect Dis"},{"key":"2019061801001764600_CIT0003","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1542\/peds.2013-0621","article-title":"Pneumococcal meningitis in children: epidemiology, serotypes, and outcomes from 1997\u20132010 in Utah","volume":"132","author":"Stockmann","year":"2013","journal-title":"Pediatrics"},{"key":"2019061801001764600_CIT0004","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1128\/CMR.00024-15","article-title":"Pneumococcal capsules and their types: past, present, and future","volume":"28","author":"Geno","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"2019061801001764600_CIT0005","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1128\/JCM.03194-15","article-title":"Pneumococcus with the \u201c6E\u201d cps locus produces serotype 6B capsular polysaccharide","volume":"54","author":"Burton","year":"2016","journal-title":"J Clin Microbiol"},{"key":"2019061801001764600_CIT0006","doi-asserted-by":"crossref","first-page":"e00262","DOI":"10.1128\/CVI.00262-17","article-title":"Development of an extended-specificity multiplex immunoassay for detection of Streptococcus pneumoniae serotype-specific antigen in urine by use of human monoclonal antibodies","volume":"24","author":"Eletu","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"2019061801001764600_CIT0007","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1371\/journal.pmed.1001017","article-title":"Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study","volume":"8","author":"Flasche","year":"2011","journal-title":"PLoS Med"},{"key":"2019061801001764600_CIT0008","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","article-title":"Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study","volume":"11","author":"Miller","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"2019061801001764600_CIT0009","first-page":"1","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study","volume":"3099","author":"Waight","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"2019061801001764600_CIT0010","volume-title":"Joint Committee on Vaccination and Immunisation. JCVI meeting minutes","year":"2017"},{"key":"2019061801001764600_CIT0011","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/cid\/cis934","article-title":"Impact of the 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in infants younger than 90 days in England and Wales","volume":"56","author":"Ladhani","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2019061801001764600_CIT0012","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3201\/eid1901.120741","article-title":"Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales","volume":"19","author":"Ladhani","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"2019061801001764600_CIT0013","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2014-2941","article-title":"13-valent pneumococcal conjugate vaccine (PCV13) in preterm versus term infants","volume":"135","author":"Martin\u00f3n-Torres","year":"2015","journal-title":"Pediatrics"},{"key":"2019061801001764600_CIT0014","doi-asserted-by":"crossref","first-page":"e20153945","DOI":"10.1542\/peds.2015-3945","article-title":"Schedules for pneumococcal vaccination of preterm infants: an RCT","volume":"138","author":"Kent","year":"2016","journal-title":"Pediatrics"},{"key":"2019061801001764600_CIT0015","first-page":"295","article-title":"Chapter 25: pneumococcal","volume-title":"Immunisation against Infectious Diseases (Green Book)","author":"UK Department of Health","year":"2010"},{"key":"2019061801001764600_CIT0016","author":"Office for National Statistics"},{"key":"2019061801001764600_CIT0017","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2334-10-12","article-title":"Effect of heptavalent pneumococcal conjugate vaccination on invasive pneumococcal disease in preterm born infants","volume":"10","author":"R\u00fcckinger","year":"2010","journal-title":"BMC Infect Dis"},{"key":"2019061801001764600_CIT0018","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1086\/512814","article-title":"Perinatal and crowding-related risk factors for invasive pneumococcal disease in infants and young children: a population-based case-control study","volume":"44","author":"Hjuler","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2019061801001764600_CIT0019","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00006454-200203000-00003","article-title":"Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants","volume":"21","author":"Shinefield","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"2019061801001764600_CIT0020","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.vaccine.2006.07.036","article-title":"Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants","volume":"25","author":"Ruggeberg","year":"2007","journal-title":"Vaccine"},{"key":"2019061801001764600_CIT0021","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/adc.88.3.206","article-title":"Hib vaccination in infants born prematurely","volume":"88","author":"Heath","year":"2003","journal-title":"Arch Dis Child"},{"key":"2019061801001764600_CIT0022","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1086\/524668","article-title":"Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody","volume":"46","author":"Lee","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2019061801001764600_CIT0023","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.earlhumdev.2010.11.003","article-title":"Transplacental transport of IgG antibodies to preterm infants: a review of the literature","volume":"87","author":"van den Berg","year":"2011","journal-title":"Early Hum Dev"},{"key":"2019061801001764600_CIT0024","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1128\/CVI.00214-10","article-title":"Responses to a conjugate pneumococcal vaccine in preterm infants immunized at 2, 3, and 4 months of age","volume":"17","author":"Moss","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"2019061801001764600_CIT0025","first-page":"1","article-title":"Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study","volume":"3099","author":"Andrews","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"2019061801001764600_CIT0026","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/cid\/cix418","article-title":"Characteristics and serotype distribution of childhood cases of invasive pneumococcal disease following pneumococcal conjugate vaccination in England and Wales, 2006\u20132014","volume":"65","author":"Oligbu","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2019061801001764600_CIT0027","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1473-3099(17)30654-0","article-title":"Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1\u2008+\u20081) compared with two primary doses and a booster (2\u2008+\u20081) in UK infants: a multicentre, parallel group randomised controlled trial","volume":"18","author":"Goldblatt","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2019061801001764600_CIT0028","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jinf.2012.02.017","article-title":"The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England","volume":"65","author":"van Hoek","year":"2012","journal-title":"J Infect"},{"key":"2019061801001764600_CIT0029","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1542\/peds.2014-0473","article-title":"Invasive pneumococcal disease after implementation of 13-valent conjugate vaccine","volume":"134","author":"Iroh Tam","year":"2014","journal-title":"Pediatrics"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/69\/1\/84\/28836121\/ciy842.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T01:00:33Z","timestamp":1560819633000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/69\/1\/84\/5114360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,3]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,10,3]]},"published-print":{"date-parts":[[2019,6,18]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy842","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,7,1]]},"published":{"date-parts":[[2018,10,3]]}}}